CAMBRIDGE, England–(BUSINESS WIRE)– #Celltherapy–Today bit.bio welcomes two new members to its independent Ethics and Sustainability Board to further support the company’s commitment to being a purpose led, ethical organisation. bit.bio is working towards a future in which precision engineered human cells enable biomedical innovation (UN SDG9) and a new generation of cures (UN SDG3). The new advisors will provide important and independent guidance as bit.bio scales their proprietary synthetic biology cell
